REMEDY : BNSSG referral pathways & Joint Formulary


Home > Children & Young People > Special Educational Needs & Disability (SEND) >

Stop over medication (STAMP)

Checked: 06-03-2023 by Vicky Ryan Next Review: 06-03-2024

Supporting Treatment and Appropriate Medication in Paediatrics

STAMP looks at how we can support children and young people with a learning disability, autism or both better.

Through STAMP NHSE want to:

  1. make the lives of children and young people with a learning disability, autism or both who are prescribed psychotropic medications better.
  2. make sure that children and young people who need medication can get it for the right reason, in the right amount for as short a time as possible.
  3. help people to understand more about these medications and have the confidence to ask why they are needed.
  4. make more non-medication treatments and support available.
  5. make sure the person with their family and paid carers are involved in any decisions to start, stop, reduce or continue taking them.
  6. get more children and young people with a learning disability, autism or both to have an annual health check, starting from the age of 14.

Resources

The NHSE STAMP page has links to STAMP resources.

https://www.england.nhs.uk/learning-disabilities/improving-health/stamp/

STOMP-STAMP is a leaflet for families of children and young people with a learning disability, autism or both who may be prescribed psychotropic medication.

Please also see the STOMP page in the adult section of Remedy for details, including resources for professionals from NHSE.



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.